Tehmeena Akhter

Ms. Tehmeena Akhter

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
AGAmama Ghaffar
Amama Ghaffar
TATehmeena Akhter
Tehmeena Akhter
PSPetter Strømme
Petter Strømme
DMDoriana Misceo
Doriana Misceo
AKAmjad Khan
Amjad Khan
SRSaima Riazuddin
Saima Riazuddin
Microtubule associated proteins (MAPs) are widely expressed in the central nervous system, and have established roles in cell proliferation, myelination, neurite formation, axon specification, outgrowth, dendrite, and synapse formation. We report eleven individuals from seven families harboring predicted pathogenic biallelic, de novo, and heterozygous variants in the NAV3 gene, which encodes the microtubule positive tip protein neuron navigator 3 (NAV3). All affected individuals have intellectual disability (ID), microcephaly, skeletal deformities, ocular anomalies, and behavioral issues. In mouse brain, Nav3 is expressed throughout the nervous system, with more prominent signatures in postmitotic, excitatory, inhibiting, and sensory neurons. When overexpressed in HEK293T and COS7 cells, pathogenic variants impaired NAV3 ability to stabilize microtubules. Further, knocking-down nav3 in zebrafish led to severe morphological defects, microcephaly, impaired neuronal growth, and behavioral impairment, which were rescued with co-injection of WT NAV3 mRNA and not by transcripts encoding the pathogenic variants. Our findings establish the role of NAV3 in neurodevelopmental disorders, and reveal its involvement in neuronal morphogenesis, and neuromuscular responses.

Verified
Journal Article
Open access
PDF file
MAMariya Ahmed
Mariya Ahmed
TATehmeena Akhter
Tehmeena Akhter
FKFiroz Kabir
Firoz Kabir
CKChristina Kilby
Christina Kilby
ANAndrew Manh Nguyen
Andrew Manh Nguyen
JAJanet Leath Alexander
Janet Leath Alexander
Congenital cataracts are an important cause of childhood visual impairment and require timely treatment to preserve visual development. Their management includes surgical removal of visually significant lens opacities, prompt optical rehabilitation, and lifelong surveillance for complications such as glaucoma and strabismus. We report a male infant with dense bilateral congenital cataracts and a multigenerational maternal history of congenital cataracts. Exome sequencing identified a heterozygous CRYBA1 variant, NM_005208.5:c.272_274del, p.(Gly91del), which was confirmed by Sanger sequencing in the proband and his affected mother. Gly91 is highly conserved, and structural modeling places the residue within a beta/gamma-crystallin Greek-key domain, where its deletion is predicted to disturb local protein folding and stability. The infant underwent sequential bilateral cataract extraction one week apart, and his aphakia was managed with contact lenses followed by spectacles. Infrequent intermittent esotropia was observed during follow-up, but no elevation of intraocular pressure or evidence of optic nerve damage was detected. At 3 years 7 months of age, best-corrected visual acuity with aphakic spectacles was 20/50 in each eye and 20/20 binocularly. The mother, who had undergone cataract surgery during infancy, subsequently developed advanced glaucoma of both eyes with marked retinal nerve fiber layer thinning. This case demonstrates the value of integrating molecular diagnosis with timely surgical treatment, optical rehabilitation, and long-term postoperative surveillance. Identification of the familial CRYBA1 variant confirmed the molecular diagnosis and supports genetic counseling, while the mother’s clinical course underscores the need for lifelong glaucoma monitoring following congenital cataract surgery.